Probably have seen this from Aunty, but may be part of reason for greater interest in PAR....
OxyContin maker Purdue Pharma reaches $270 million settlement over opioid crisis
Updated about 2 hours ago
Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.
VIDEO: Purdue Pharma denied any wrongdoing but agreed to a settlement. (ABC News)
RELATED STORY: 'They should be in jail with El Chapo': Gallery rejects donation from family linked to opioid crisis
RELATED STORY: The small-town doctor taking on the billionaire family blamed for America's opioid crisis
RELATED STORY: Why people use painkillers for emotional relief
OxyContin maker Purdue Pharma LP and members of the wealthy Sackler family that own the company have reached a $US270 million ($378 million) settlement to resolve a lawsuit accusing the drugmaker of fuelling an opioid abuse epidemic.
Key points:
The settlement in the case, which was brought by the US state of Oklahoma, was unveiled by Attorney-General Mike Hunter on Tuesday.
- Oklahoma's Attorney-General accused Purdue Pharma of downplaying opioid addiction risks
- Purdue's legal team argued labels featured a warning about the risk of opioid abuse and misuse
- The lawsuit was due to go to a trial before a jury in May
It was the first to result from a wave of recent lawsuits accusing Purdue of deceptively marketing painkillers, helping create a deadly crisis sweeping the US.
Mr Hunter's 2017 lawsuit was set to go to a jury on May 28 in what would have been the first trial to result from roughly 2,000 lawsuits filed in federal and state courts nationwide against Purdue and other drugmakers.
Mr Hunter alleged Purdue, Johnson & Johnson and Teva Pharmaceutical Industries Ltd engaged in deceptive marketing that played down the risks of addiction associated with opioids while overstating their benefits, contributing to the epidemic.
Opioids, including prescription painkillers, heroin and fentanyl, were involved in a record 47,600 overdose deaths in 2017 in the US, according to the US Centres for Disease Control and Prevention.
- Forums
- ASX - By Stock
- PAR
- The competition and their side effects
The competition and their side effects, page-18
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $82.30M |
Open | High | Low | Value | Volume |
28.0¢ | 28.0¢ | 26.5¢ | $281.4K | 1.024M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3499 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 161588 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47906 | 0.245 |
3 | 82048 | 0.240 |
2 | 32293 | 0.235 |
8 | 110599 | 0.230 |
7 | 89672 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 13363 | 1 |
0.255 | 34148 | 4 |
0.260 | 6415 | 2 |
0.270 | 19081 | 2 |
0.275 | 13636 | 2 |
Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |